Christine R Bryke
Research Subjects
Christine R Bryke has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Albert K. Ho
Nichols Institute
1 shared publication - Aurelia Meloni-Ehrig
Ameripath Florida, 8150 Chancellor Dr Ste 110, Orlando, FL 32809, USA
1 shared publication - Dan Jones
Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, 20151 Chantilly, VA, USA
1 shared publication - Debra Boles
Department of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA, 20151, USA
1 shared publication - Heather R. Sanders
Department of Hematology and Oncology, Quest Diagnostics Nichols Institute, 33608 Ortega Highway, San Juan Capistrano, CA, 92675, USA.
1 shared publication - Jennifer Otani-Rosa
Department of Cytogenetics, Quest Diagnostics Nichols Institute, 14225 Newbrook Drive, Chantilly, VA, 20151, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 5 (1) , 44
Incidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas
Anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangements have been reported in 2-13% of patients with non-small cell lung cancer (NSCLC). Patients with ALK rearrangements do not respond to EGFR-specific tyrosine kinase inhibitors (TKIs); however, they do benefit from small molecule inhibitors targeting ALK.
- 1 January 2012
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 5 (1) , 44
Open AccessIncidence and patterns of ALK FISH abnormalities seen in a large unselected series of lung carcinomas
Anaplastic lymphoma receptor tyrosine kinase (ALK) gene rearrangements have been reported in 2-13% of patients with non-small cell lung cancer (NSCLC). Patients with ALK rearrangements do not respond to EGFR-specific tyrosine kinase inhibitors (TKIs); however, they do benefit from small molecule inhibitors targeting ALK.